Loading
Latest filing published 28 Sept 2026 for Legend Biotech Corp.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Patrick John Casey is known so far (28 September 2026): a share grant, in Legend Biotech Corp. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration